Perturbation of electron transfer efficiency by downregulating SCAF1 specifically affects hypoxic pancreatic cancer, breast and endometrial cancer proliferation, metabolism, and in vivo tumor growth42,43. Here, SCAF1 is linked to endometrial cancer.